▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3542 by analyst upside · 2026-11-12
STAA
STAAR Surgical Company
Healthcare · Market Cap $1B · P/E 2669.0x
ANALYST PRICE TARGET
+7.0%
implied upside to consensus target
Current Price $26.69
Consensus Target $28.56
Bull Target $37.0
Bear Target $19.0
Analysts Covering 9
ANALYST CONSENSUS - HOLD
Strong Buy
0
Buy
3
Hold
5
Sell
1
52-Week Low $15.59
52-Week High $35.87
YTD Return +13.1%
FUNDAMENTALS
Market Cap $1B
P/E Ratio (TTM) 2669.0x
Forward P/E 23.1x
EPS (TTM) $0.01
PEG Ratio 0.76
Dividend Yield N/A
Revenue (TTM) $328M
Profit Margin 0.2%
52-WEEK RANGE
52-Week Low $15.59
52-Week High $35.87
Current Price $26.69
Bear Target $19.0
Bull Target $37.0
● Now $26.69 ● Target $28.56
TRADING DATA
Avg Volume 907K
YTD Return +13.1%
Analyst Count 9
Consensus Hold
Upside to Target +7.0%
Last Updated 2026-11-12

ANALYST SUMMARY

STAAR Surgical Company (STAA) is currently trading at $26.69 with a Wall Street consensus price target of $28.56, implying potential upside of 7.0% over the next 12 months. 9 analysts currently cover STAA, with a consensus rating of Hold - 33% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $37.0, while the most cautious has a target of $19.0.

STAA operates in the Healthcare sector with a market capitalisation of $1B. The stock is up 13.1% year-to-date and is currently trading near the upper end of its 52-week range of $15.59 – $35.87.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for STAA, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Stifel ↑ Upgrade
Hold → Buy 2026-09-29 Building track record
Jefferies - Reiterated
Buy → Buy 2026-09-22 50% win rate (6 calls)
Stifel - Reiterated
Hold → Hold 2026-08-17 Building track record
UBS - Reiterated
Sell → Sell 2026-08-13 33% win rate (6 calls)
Wedbush - Reiterated
Outperform → Outperform 2026-08-13 Building track record
Jefferies - Reiterated
Buy → Buy 2026-08-13 50% win rate (6 calls)
Wedbush reit
Outperform → Outperform 2026-08-04 Building track record
UBS ● Initiated
Sell 2026-07-28 33% win rate (6 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
37
out of 100
Coverage depth
18/30
Consensus clarity
17/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →